MaxCyte, Inc. Share Price
NASDAQ: MXCT | Micro CapMaxCyte, Inc. Stock Performance
Open $1.35 | Prev. Close $1.25 | Circuit Range N/A |
Day Range $1.22 - $1.35 | Year Range $0.65 - $1.86 | Volume 54,843 |
Average Traded $1.26 |
MaxCyte, Inc. Share Price Today
As of 14 August 2026, MaxCyte, Inc.'s share price is $1.26. The stock opened at $1.35, compared to its previous close of $1.25. During today's trading session, MaxCyte, Inc.'s share price traded between $1.22 and $1.35, with an average price of $1.29. Over the past 52 weeks, the stock has recorded a high of $1.86 and a low of $0.65. In terms of performance, MaxCyte, Inc.'s share price has risen by 55.36% over the last six months and is down 9.68% on a year-on-year basis.
MaxCyte, Inc. Share Price Chart
MaxCyte, Inc. Stock Fundamentals & Key Indicators
Market Cap $134.10M | PE Ratio (TTM) -3.00 | Dividend Yield N/A |
EPS (TTM) $-0.42 | Revenue (TTM) $33.03M | Return On Equity (TTM) -26.02% |
Profit Margin -135.14% | Debt to Equity 0.08 | Quarterly Earnings Growth YoY -7.43% |
MaxCyte, Inc. Quarterly Profit & Loss
All figures in USD
MaxCyte, Inc. Annual Profit & Loss
All figures in USD
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.06 | $1.26 | +19.43% |
Jul 2026 | $1.24 | $1.05 | -14.23% |
Jun 2026 | $1.20 | $1.23 | +1.65% |
May 2026 | $0.86 | $1.21 | +37.66% |
Apr 2026 | $0.70 | $0.88 | +24.86% |
Mar 2026 | $0.80 | $0.70 | -13.19% |
Feb 2026 | $0.90 | $0.81 | -11.27% |
Jan 2026 | $1.55 | $0.91 | -40.84% |
Dec 2025 | $1.75 | $1.54 | -11.71% |
Nov 2025 | $1.52 | $1.75 | +14.01% |
Oct 2025 | $1.57 | $1.53 | -3.46% |
Sep 2025 | $1.36 | $1.59 | +13.98% |
MXCT Share Price FAQs
What is MaxCyte, Inc. share price today?
What is the 52 week high and 52 week low of MaxCyte, Inc. stock?
What is MXCT's market capitalisation today?
What is MXCT's net income for the last quarter?
What is the 5 year returns of MXCT?
What is the high & low stock price of MXCT today?
Can I buy MXCT shares in India?